Medical devices, healthcare technology and the business of care
510(k) clearance · K261679

BlineSlide

Deep Breathe, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONK261679

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for BlineSlide, a 510(k) submitted by Deep Breathe, Inc. of London, Canada, under 510(k) number K261679. The device falls under the classification name Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer, regulation number 892.2060, product code POK, in the Radiology specialty and review panel. The application was received 05/21/2026 and decided 10/23/2026. SESE denotes clearance to market, not premarket approval of a new device system.

The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The applicant contact and correspondent are listed as Robert Arntfield. The public record does not include the summary statement, so the specific software functions, intended use wording, and any performance data supporting equivalence remain unknown from this source.

No clinical, efficacy, or labeling conclusions are drawn here; those details would require the underlying FDA decision documents, which were not available in the provided material.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 23, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261679
Regulatory pathway
510(k) premarket notification
Product code
POK
Decision code
SESE
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer.

Product code
POK
FDA device class
2

FDA decision timeline

  1. K261679 received

    Application receipt date recorded by FDA.

  2. K261679 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Deep Breathe, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
London

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records